文献速递间质性肺疾病

吸烟与特发性肺纤维化发病风险:韩国全国人群队列研究

Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study.
PubMed 文献 · Thorax · 2021-09-30

该研究利用韩国国家健康信息数据库,纳入2009至2012年参加健康体检者并排除既往特发性肺纤维化(IPF)诊断者,通过问卷收集吸烟状态与吸烟量,随访至2016年以ICD-10编码和医疗理赔识别新发IPF。结果显示当前吸烟者和既往吸烟者IPF风险均显著高于从不吸烟者,且风险随吸烟强度和年限增加呈剂量反应关系。

要点

  • 当前吸烟者IPF风险高于从不吸烟者(aHR 1.66)。
  • 既往吸烟者IPF风险亦升高(aHR 1.42),但低于当前吸烟者。
  • 吸烟强度与年限增加,IPF发病风险随之升高。

核心结论

  • 吸烟显著增加特发性肺纤维化的发病风险。
  • 当前吸烟者的IPF风险高于既往吸烟者。
  • 吸烟与IPF发病之间存在剂量反应关系。

研究设计与样本

  • 基于韩国国家健康信息数据库的全国性人群队列研究。
  • 纳入2009至2012年间参加健康体检服务者,排除既往诊断IPF者。
  • 吸烟状态与吸烟量经问卷收集,随访至2016年识别新发IPF。
  • 采用Cox比例风险模型计算IPF发病的调整风险比(aHR)。

主要发现

  • 数据库登记的23 242 836名参与者中识别出新发IPF 25 113例(0.11%)。
  • 当前吸烟者IPF风险高于从不吸烟者,aHR为1.66(95% CI 1.61至1.72)。
  • 既往吸烟者IPF风险高于从不吸烟者,aHR为1.42(95% CI 1.37至1.48)。
  • 当前吸烟者IPF风险高于既往吸烟者,aHR为1.17(95% CI 1.13至1.21)。
  • IPF发病风险随吸烟强度和吸烟年限增加而升高。

临床怎么用

  • 对呼吸科就诊者应询问吸烟状态与吸烟量,将吸烟史纳入IPF风险关注因素。
  • 对当前吸烟者强调戒烟,以降低包括IPF在内的发病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Smoking has been considered an important risk factor for idiopathic pulmonary fibrosis (IPF) incidence. However, there are no population-based large-scale studies demonstrating the effects of smoking on the development of IPF. We aimed to evaluate the effect of smoking on IPF development using a nationwide population-based cohort. METHODS: Using the Korean National Health Information Database, we enrolled individuals who had participated in the health check-up service between 2009 and 2012. Participants having a prior diagnosis of IPF were excluded. The history of smoking status and quantity was collected by a questionnaire. We identified all cases of incident IPF through 2016 on the basis of ICD-10 codes for IPF and medical claims. Cox proportional hazards models were used to calculate the adjusted HR (aHR) of the development of IPF. RESULTS: A total of 25 113 individuals (0.11%) with incident IPF were identified out of 23 242 836 participants registered in the database. The risk of IPF was significantly higher in current and former smokers than in never smokers, with an aHR of 1.66 (95% CI 1.61 to 1.72) and 1.42 (95% CI 1.37 to 1.48), respectively. Current smokers had a higher risk of IPF than former smokers (aHR 1.17, 95% CI 1.13 to 1.21). The risk of IPF development increased as the smoking intensity and duration increased. CONCLUSION: Smoking significantly increased the risk of IPF development. Current smokers had a higher risk of IPF than former smokers. A dose-response relationship was observed between smoking and the development of IPF.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Bae W, Lee CH, Lee J, et al. Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study. Thorax. 2021. PMID: 34593614. doi:10.1136/thoraxjnl-2020-215386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。